Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
Authors
Keywords
NAFLD, Fatty liver, Curcumin, Inflammation, NASH
Journal
BMC GASTROENTEROLOGY
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-25
DOI
10.1186/s12876-019-1055-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
- (2018) Francesco Giuseppe Foschi et al. BMC GASTROENTEROLOGY
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male Wistar rats: Potential role of serine kinases
- (2016) Nachimuthu Maithilikarpagaselvi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
- (2016) Mehran Rahimlou et al. Hepatitis Monthly
- Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease
- (2016) Azita Hekmatdoost et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation
- (2016) Maryam Noori et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals
- (2016) Alexa Kocher et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
- (2016) Sepideh Rahmani et al. PHYTOTHERAPY RESEARCH
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
- (2014) Tannaz Eslamparast et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?
- (2013) Alireza Ghaemi et al. Hepatitis Monthly
- Synergistic effect of black tea and curcumin in improving the hepatotoxicity induced by aflatoxin B1 in rats
- (2013) Abeer A Alm-Eldeen et al. TOXICOLOGY AND INDUSTRIAL HEALTH
- Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration
- (2012) Dilek Coban et al. MOLECULAR NUTRITION & FOOD RESEARCH
- New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases
- (2011) Adeeb Shehzad et al. EUROPEAN JOURNAL OF NUTRITION
- Ameliorative effect of curcumin on hepatotoxicity induced by chloroquine phosphate
- (2010) J.J. Dattani et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-α
- (2009) M. Carmen Ramirez-Tortosa et al. FREE RADICAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now